Indiplon
N/A
Report date: 2022/07/06 17:25:45
NME
Base Information
Drug NameIndiplon
Drug Alias Name +[8]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesNeurocrine Biosciences Inc
Active IndicationsN/A
Inactive Indications